T1	CHEM 71 79	NKTR-214
#1	AnnotatorNotes T1	C4309517; NKTR-214; Amino Acid, Peptide, or Protein · Biologically Active Substance
T2	CHEM 57 66	nivolumab
#2	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	CHEM 89 98	nivolumab
#3	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 99 110	monoterapia
#4	AnnotatorNotes T4	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T5	DISO 164 180	cáncer de vejiga
#5	AnnotatorNotes T5	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T6	CHEM 336 344	NKTR-214
#6	AnnotatorNotes T6	C4309517; NKTR-214; Amino Acid, Peptide, or Protein · Biologically Active Substance
T7	ANAT 200 227	pared muscular de la vejiga
T8	PROC 299 309	adyuvancia
T9	PROC 250 278	Estudio fase 3, aleatorizado
T10	PROC 283 296	neoadyuvancia
#7	AnnotatorNotes T10	C0600558; Neoadjuvant Therapy; Therapeutic or Preventive Procedure
T11	CHEM 322 331	nivolumab
#8	AnnotatorNotes T11	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	CHEM 354 363	nivolumab
#9	AnnotatorNotes T12	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T13	PROC 364 375	monoterapia
#10	AnnotatorNotes T13	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T14	DISO 430 462	cáncer de vejiga musculoinvasivo
T15	CHEM 478 488	cisplatino
#11	AnnotatorNotes T15	C0008838; cisplatin; Inorganic Chemical · Pharmacologic Substance
T16	DISO 512 528	Cáncer de vejiga
#12	AnnotatorNotes T16	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T17	DISO 555 587	Cáncer de vejiga musculoinvasivo
T18	DISO 616 620	CVMI
#13	AnnotatorNotes T18	C4725841; Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Neoplastic Process
T19	PROC 657 671	diagnosticados
#14	AnnotatorNotes T19	C0011900; Diagnosis; Diagnostic Procedure
T20	PROC 681 723	resección transuretral del tumor de vejiga
#15	AnnotatorNotes T20	C0401496; Transurethral resection of bladder neoplasm; Therapeutic or Preventive Procedure
T21	DISO 708 723	tumor de vejiga
T22	PROC 725 730	RTUTV
#16	AnnotatorNotes T22	C0401496; Transurethral resection of bladder neoplasm; Therapeutic or Preventive Procedure
T23	PROC 782 784	CR
#17	AnnotatorNotes T23	C0194401; Complete cystectomy; Therapeutic or Preventive Procedure
T24	ANAT 1748 1750	GL
#18	AnnotatorNotes T24	C0024204; lymph nodes; Body Part, Organ, or Organ Component | C1269047; Entire lymph node; Body Part, Organ, or Organ Component lymph nodes
T25	PROC 943 967	tratamiento neoadyuvante
#19	AnnotatorNotes T25	C0600558; Neoadjuvant Therapy; Therapeutic or Preventive Procedure
T26	CHEM 1086 1096	cisplatino
#20	AnnotatorNotes T26	C0008838; cisplatin; Inorganic Chemical · Pharmacologic Substance
T27	ANAT 1163 1168	renal
#21	AnnotatorNotes T27	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T28	PROC 1170 1199	tasa de filtración glomerular
#22	AnnotatorNotes T28	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T29	PROC 1201 1204	TFG
#23	AnnotatorNotes T29	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T30	PROC 1236 1239	TFG
#24	AnnotatorNotes T30	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T31	PROC 1291 1317	aclaramiento de creatinina
#25	AnnotatorNotes T31	C0373595; Creatinine clearance measurement; Laboratory Procedure
T32	PROC 1407 1433	fórmula de Cockcroft-Gault
#26	AnnotatorNotes T32	C2711451; Estimation of creatinine clearance by Cockcroft-Gault formula; Laboratory Procedure
T33	CHEM 1377 1387	creatinina
#27	AnnotatorNotes T33	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T34	ANAT 1388 1394	sérica
#28	AnnotatorNotes T34	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T35	ANAT 1395 1405	plasmática
#29	AnnotatorNotes T35	C0032105; Plasma; Body Substance
T36	DISO 1440 1456	Pérdida auditiva
#30	AnnotatorNotes T36	C1384666; hearing impairment; Disease or Syndrome
T37	DISO 1553 1577	Acontecimientos Adversos
#31	AnnotatorNotes T37	C0877248; Adverse event; Pathologic Function
T38	DISO 1600 1621	Neuropatía periférica
#32	AnnotatorNotes T38	C0031117; Peripheral Neuropathy; Disease or Syndrome
T39	DISO 2038 2043	CVNMI
T40	PROC 1686 1702	Pruebas clínicas
#33	AnnotatorNotes T40	C0008976; Clinical Trials; Research Activity
T41	DISO 1706 1722	cáncer de vejiga
#34	AnnotatorNotes T41	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T42	ANAT 1727 1746	ganglios linfáticos
#35	AnnotatorNotes T42	C0024204; lymph nodes; Body Part, Organ, or Organ Component | C1269047; Entire lymph node; Body Part, Organ, or Organ Component
T43	PROC 1795 1816	tratamiento sistémico
T44	PROC 1818 1830	radioterapia
#36	AnnotatorNotes T44	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T45	PROC 1833 1840	cirugía
#37	AnnotatorNotes T45	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T46	DISO 1854 1870	cáncer de vejiga
#38	AnnotatorNotes T46	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T47	PROC 1889 1897	biopsias
#39	AnnotatorNotes T47	C0005558; Biopsy; Diagnostic Procedure
T48	PROC 1910 1921	tratamiento
#40	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	CHEM 1960 1963	BCG
#41	AnnotatorNotes T49	C2698319; Bacillus Calmette-Guerin Antigen; Immunologic Factor
T50	PROC 1972 1996	tratamiento intravesical
T51	DISO 2001 2036	cáncer de vejiga no musculoinvasivo
T52	PROC 2099 2110	tratamiento
#42	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	DISO 2137 2156	carcinoma urotelial
#43	AnnotatorNotes T53	C0007138; Carcinoma, Transitional Cell; Neoplastic Process
T54	DISO 2158 2160	CU
#44	AnnotatorNotes T54	C0007138; Carcinoma, Transitional Cell; Neoplastic Process
T55	ANAT 2169 2194	vías urinarias superiores
T56	ANAT 2196 2204	uréteres
#45	AnnotatorNotes T56	C0041951; Ureter; Body Part, Organ, or Organ Component | C1281572; Entire ureter; Body Part, Organ, or Organ Component
T57	ANAT 2207 2219	pelvis renal
#46	AnnotatorNotes T57	C0227666; Renal pelvis; Body Part, Organ, or Organ Component | C1284489; Entire renal pelvis; Body Part, Organ, or Organ Component
T58	DISO 2246 2248	CU
#47	AnnotatorNotes T58	C0007138; Carcinoma, Transitional Cell; Neoplastic Process
T59	ANAT 2273 2279	vejiga
#48	AnnotatorNotes T59	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T60	PROC 2354 2363	protocolo
#49	AnnotatorNotes T60	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T61	PROC 121 146	tratamiento de referencia
T62	ANAT 174 180	vejiga
#50	AnnotatorNotes T62	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T63	PROC 386 411	tratamiento de referencia
T64	ANAT 440 446	vejiga
#51	AnnotatorNotes T64	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T65	ANAT 522 528	vejiga
#52	AnnotatorNotes T65	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T66	ANAT 565 571	vejiga
#53	AnnotatorNotes T66	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T67	ANAT 717 723	vejiga
#54	AnnotatorNotes T67	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T68	PROC 839 841	CR
#55	AnnotatorNotes T68	C0194401; Complete cystectomy; Therapeutic or Preventive Procedure
T69	PROC 916 918	CR
#56	AnnotatorNotes T69	C0194401; Complete cystectomy; Therapeutic or Preventive Procedure
T70	DISO 1139 1168	Deterioro de la función renal
#57	AnnotatorNotes T70	C0232807; Decreased renal function; Finding (?) | C1565489; Renal Insufficiency; Disease or Syndrome (?)
T71	CHEM 1307 1317	creatinina
#58	AnnotatorNotes T71	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T72	PROC 1377 1405	creatinina sérica/plasmática
T73	PROC 1881 1886	TRUTV
T74	ANAT 1716 1722	vejiga
#59	AnnotatorNotes T74	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T75	DISO 1727 1763	ganglios linfáticos (GL) patológicos
T76	DISO 1766 1777	metastásico
#60	AnnotatorNotes T76	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T77	ANAT 1864 1870	vejiga
#61	AnnotatorNotes T77	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T78	CHEM 1933 1958	bacilo de Calmette-Guerin
#62	AnnotatorNotes T78	C0004886; BCG Vaccine; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T79	ANAT 2011 2017	vejiga
#63	AnnotatorNotes T79	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T80	ANAT 2147 2156	urotelial
#64	AnnotatorNotes T80	C0227598; Urothelium; Tissue
T81	DISO 2239 2243	CVMI
#65	AnnotatorNotes T81	C4725841; Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Neoplastic Process
T82	Date 13 17	2018
T83	LIVB 150 159	pacientes
#66	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T84	LIVB 416 425	pacientes
#67	AnnotatorNotes T84	C0030705; Patients; Patient or Disabled Group
T85	Neg_cue 463 465	no
T86	LIVB 738 746	paciente
#68	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	LIVB 792 799	urólogo
#69	AnnotatorNotes T87	C0260314; Urologists; Professional or Occupational Group
T88	LIVB 868 877	pacientes
#70	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
T90	LIVB 1062 1071	pacientes
#71	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T96	Neg_cue 1781 1783	No
T97	Route 1984 1996	intravesical
T100	Duration 2059 2077	al menos 6 semanas
T103	PHYS 1448 1456	auditiva
#72	AnnotatorNotes T103	C0018767; Hearing; Physiologic Function
T89	Neg_cue 1072 1085	inelegibles a
T91	PHYS 1155 1168	función renal
#73	AnnotatorNotes T91	C0232804; Renal function; Organ or Tissue Function
T92	PHYS 1178 1199	filtración glomerular
#74	AnnotatorNotes T92	C0232809; Glomerular filtration; Organ or Tissue Function
T93	PROC 970 986	Estado funcional
#75	AnnotatorNotes T93	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T94	ANAT 1189 1199	glomerular
#76	AnnotatorNotes T94	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T15 Negated
A2	Assertion T26 Negated
A3	Assertion T43 Negated
A4	Assertion T44 Negated
A5	Assertion T45 Negated
A7	Status T48 History_of
A8	Status T78 History_of
A9	Status T49 History_of
A10	Status T50 History_of
A11	Status T81 History_of
A12	Status T58 History_of
A6	Status T43 History_of
A13	Status T44 History_of
A14	Status T45 History_of
A15	Status T73 History_of
A16	Status T47 History_of
#77	AnnotatorNotes T9	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity
#78	AnnotatorNotes T97	C1522448; Intravesical Route of Drug Administration; Functional Concept
#79	AnnotatorNotes T8	C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
#80	AnnotatorNotes T17	C4725841; Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Neoplastic Process
#81	AnnotatorNotes T14	C4725841; Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Neoplastic Process
#82	AnnotatorNotes T21	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
#83	AnnotatorNotes T72	C2362094; Creatinine in serum or plasma; Laboratory or Test Result 
#84	AnnotatorNotes T73	C0401496; Transurethral resection of bladder neoplasm; Therapeutic or Preventive Procedure
#85	AnnotatorNotes T39	C5418781; Non-Muscle Invasive Bladder Urothelial Carcinoma; Neoplastic Process
#86	AnnotatorNotes T51	C4725841; Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall; Neoplastic Process
#87	AnnotatorNotes T50	C1636162; Intravesical administration of treatment; Therapeutic or Preventive Procedure 
#88	AnnotatorNotes T55	C1278977; Entire upper urinary tract; Body System | C0729865; Upper urinary tract structure; Body Part, Organ, or Organ Component
T95	Neg_cue 2256 2258	no
T98	Quantifier_or_Qualifier 2259 2279	limitado a la vejiga
A17	Assertion T98 Negated
T99	Neg_cue 2018 2020	no
T101	Observation 2021 2036	musculoinvasivo
A18	Assertion T101 Negated
#89	AnnotatorNotes T101	C4725840; Muscle Invasion; Finding
R1	Negation Arg1:T85 Arg2:T15	
R2	Negation Arg1:T89 Arg2:T26	
R3	Negation Arg1:T96 Arg2:T43	
R4	Negation Arg1:T96 Arg2:T44	
R5	Negation Arg1:T96 Arg2:T45	
R6	Negation Arg1:T99 Arg2:T101	
R7	Negation Arg1:T95 Arg2:T98	
T102	Spec_cue 2281 2290	Se pueden
T104	Quantifier_or_Qualifier 2299 2304	otros
A19	Assertion T104 Speculated
R8	Speculation Arg1:T102 Arg2:T104	
T105	CONC 2305 2327	criterios de inclusión
A20	Assertion T105 Speculated
#90	AnnotatorNotes T105	C1512693; Inclusion Criteria; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T105 Arg2:T104	
T106	CONC 2328 2337	exclusión
A21	Assertion T106 Speculated
#91	AnnotatorNotes T106	C0680251; Exclusion Criteria; Functional Concept
R10	Has_Quantifier_or_Qualifier Arg1:T106 Arg2:T104	
R11	Speculation Arg1:T102 Arg2:T106	
R12	Speculation Arg1:T102 Arg2:T105	
R13	Combined_with Arg1:T2 Arg2:T1	
R14	Used_for Arg1:T3 Arg2:T4	
#92	AnnotatorNotes T61	C2936643; Standard of Care; Health Care Activity
#93	AnnotatorNotes T63	C2936643; Standard of Care; Health Care Activity
R15	Experiences Arg1:T83 Arg2:T2	
R16	Experiences Arg1:T83 Arg2:T3	
R17	Experiences Arg1:T83 Arg2:T61	
R18	Experiences Arg1:T83 Arg2:T5	
R19	Location_of Arg1:T62 Arg2:T5	
T107	Observation 188 227	invadido la pared muscular de la vejiga
#94	AnnotatorNotes T107	C4725840; Muscle Invasion; Finding
R20	Location_of Arg1:T7 Arg2:T107	
R21	Overlap Arg1:T5 Arg2:T107	
T108	Observation 447 462	musculoinvasivo
R23	Location_of Arg1:T64 Arg2:T14	
#95	AnnotatorNotes T108	C4725840; Muscle Invasion; Finding
R24	Location_of Arg1:T65 Arg2:T16	
R25	Location_of Arg1:T66 Arg2:T17	
T109	Observation 572 587	musculoinvasivo
#96	AnnotatorNotes T109	C4725840; Muscle Invasion; Finding
R27	Experiences Arg1:T84 Arg2:T14	
R28	Experiences Arg1:T84 Arg2:T15	
R29	Experiences Arg1:T84 Arg2:T63	
R30	Experiences Arg1:T84 Arg2:T10	
R31	Experiences Arg1:T84 Arg2:T8	
R32	Experiences Arg1:T84 Arg2:T11	
R33	Combined_with Arg1:T11 Arg2:T6	
R34	Experiences Arg1:T84 Arg2:T12	
R35	Used_for Arg1:T12 Arg2:T13	
#97	AnnotatorNotes T7	C0458421; Wall of bladder; Body Part, Organ, or Organ Component (?) 
R36	Before Arg1:T20 Arg2:T19	
R38	Location_of Arg1:T67 Arg2:T21	
R40	Before Arg1:T22 Arg2:T19	
T110	Observation 641 643	T2
#98	AnnotatorNotes T110	C0475373; Tumor stage T2; Finding
T111	Observation 644 647	T4a
#99	AnnotatorNotes T111	C0475395; Tumor stage T4a; Finding
R41	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T110	
R42	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T111	
T112	Observation 649 651	N0
#100	AnnotatorNotes T112	C0441959; Node stage N0; Finding
R43	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T112	
T113	Observation 653 655	M0
#101	AnnotatorNotes T113	C0445034; M0 Stage Finding; Finding
R44	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T113	
R45	Experiences Arg1:T86 Arg2:T23	
R46	Experiences Arg1:T86 Arg2:T68	
T114	Observation 807 823	estar de acuerdo
#102	AnnotatorNotes T114	C0600109; Willing; Finding (?)
R47	Overlap Arg1:T114 Arg2:T68	
T115	Observation 884 900	estar de acuerdo
#103	AnnotatorNotes T115	C0600109; Willing; Finding (?)
R48	Overlap Arg1:T115 Arg2:T69	
R49	After Arg1:T69 Arg2:T25	
R50	Experiences Arg1:T88 Arg2:T69	
R51	Experiences Arg1:T88 Arg2:T25	
T116	CONC 991 1025	Eastern Cooperative Oncology Group
#104	AnnotatorNotes T116	C1520224; ECOG performance status; Intellectual Product
T117	CONC 1027 1031	ECOG
#105	AnnotatorNotes T117	C1520224; ECOG performance status; Intellectual Product
R52	Used_for Arg1:T116 Arg2:T93	
R53	Used_for Arg1:T117 Arg2:T93	
T118	Result_or_Value 1036 1041	0 o 1
R54	Has_Result_or_Value Arg1:T116 Arg2:T118	
R55	Has_Result_or_Value Arg1:T117 Arg2:T118	
R56	Experiences Arg1:T90 Arg2:T26	
R57	Location_of Arg1:T27 Arg2:T70	
R58	Location_of Arg1:T27 Arg2:T91	
R60	Location_of Arg1:T94 Arg2:T92	
R61	Location_of Arg1:T94 Arg2:T28	
R62	Location_of Arg1:T94 Arg2:T29	
T119	Result_or_Value 1206 1227	≥ 30 pero < 60 ml/min
R65	Has_Result_or_Value Arg1:T28 Arg2:T119	
R66	Has_Result_or_Value Arg1:T29 Arg2:T119	
R72	Location_of Arg1:T34 Arg2:T72	
R73	Location_of Arg1:T35 Arg2:T72	
T120	Quantifier_or_Qualifier 1501 1510	grado ≥ 2
T121	CONC 1518 1577	Criterios de Terminología Común de Acontecimientos Adversos
#106	AnnotatorNotes T121	C1516728; National Cancer Institute common terminology criteria for adverse events; Intellectual Product
T122	CONC 1579 1584	CTCAE
#107	AnnotatorNotes T122	C1516728; National Cancer Institute common terminology criteria for adverse events; Intellectual Product
R76	Has_Quantifier_or_Qualifier Arg1:T121 Arg2:T120	
R77	Has_Quantifier_or_Qualifier Arg1:T122 Arg2:T120	
T123	CONC 1642 1647	CTCAE
#108	AnnotatorNotes T123	C1516728; National Cancer Institute common terminology criteria for adverse events; Intellectual Product
T124	Quantifier_or_Qualifier 1625 1634	grado ≥ 2
R78	Has_Quantifier_or_Qualifier Arg1:T123 Arg2:T124	
R75	Location_of Arg1:T74 Arg2:T41	
R81	Before Arg1:T41 Arg2:T76	
R82	Overlap Arg1:T41 Arg2:T75	
R84	Location_of Arg1:T77 Arg2:T46	
R85	Used_for Arg1:T78 Arg2:T48	
R86	Used_for Arg1:T49 Arg2:T48	
R87	Has_Route_or_Mode Arg1:T50 Arg2:T97	
R88	Location_of Arg1:T79 Arg2:T51	
R89	Location_of Arg1:T79 Arg2:T39	
R91	Overlap Arg1:T101 Arg2:T39	
T125	CONC 2048 2058	se terminó
#109	AnnotatorNotes T125	C1272693; Ended - status; Qualitative Concept
R92	Overlap Arg1:T125 Arg2:T100	
R93	Before Arg1:T125 Arg2:T52	
R94	Before Arg1:T48 Arg2:T100	
R95	Before Arg1:T48 Arg2:T52	
R96	Location_of Arg1:T80 Arg2:T53	
R97	Location_of Arg1:T80 Arg2:T54	
R98	Location_of Arg1:T55 Arg2:T53	
R99	Location_of Arg1:T55 Arg2:T54	
R100	Location_of Arg1:T56 Arg2:T53	
R101	Location_of Arg1:T56 Arg2:T54	
R102	Location_of Arg1:T57 Arg2:T53	
R103	Location_of Arg1:T57 Arg2:T54	
R104	Has_Quantifier_or_Qualifier Arg1:T81 Arg2:T98	
R105	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T98	
R106	Location_of Arg1:T59 Arg2:T81	
R107	Location_of Arg1:T59 Arg2:T58	
R110	Location_of Arg1:T42 Arg2:T75	
R111	Location_of Arg1:T24 Arg2:T75	
#110	AnnotatorNotes T43	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
#111	AnnotatorNotes T104	C0205394; Other; Qualitative Concept
#112	AnnotatorNotes T75	C5171569; Lymph node involvement; Finding | C4682923; Bladder Cancer Pathologic Regional Lymph Nodes TNM Finding v8; Finding
A22	Assertion T125 Hypothetical
A23	Assertion T100 Hypothetical
A24	Experiencer T83 Patient
A25	Experiencer T84 Patient
A26	Experiencer T86 Patient
A27	Experiencer T87 Other
A28	Experiencer T88 Patient
A29	Experiencer T90 Patient
